Rank | Gene Set | Z-score |
---|---|---|
1 | complement activation, alternative pathway (GO:0006957) | 7.32190538 |
2 | regulation of protein activation cascade (GO:2000257) | 6.21493156 |
3 | negative regulation of fibrinolysis (GO:0051918) | 6.19671957 |
4 | regulation of fibrinolysis (GO:0051917) | 6.10687636 |
5 | ethanol oxidation (GO:0006069) | 6.00564379 |
6 | regulation of complement activation (GO:0030449) | 5.93488666 |
7 | L-phenylalanine catabolic process (GO:0006559) | 5.72879030 |
8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.72879030 |
9 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.64467305 |
10 | protein carboxylation (GO:0018214) | 5.64467305 |
11 | L-phenylalanine metabolic process (GO:0006558) | 5.31797661 |
12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.31797661 |
13 | epoxygenase P450 pathway (GO:0019373) | 5.25213730 |
14 | exogenous drug catabolic process (GO:0042738) | 5.23300579 |
15 | omega-hydroxylase P450 pathway (GO:0097267) | 5.11847225 |
16 | drug catabolic process (GO:0042737) | 5.11447628 |
17 | glyoxylate metabolic process (GO:0046487) | 5.05460035 |
18 | regulation of plasminogen activation (GO:0010755) | 5.02880050 |
19 | ethanol metabolic process (GO:0006067) | 4.77480724 |
20 | fibrinolysis (GO:0042730) | 4.70519458 |
21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.68518295 |
22 | blood coagulation, intrinsic pathway (GO:0007597) | 4.60006039 |
23 | urea metabolic process (GO:0019627) | 4.44037370 |
24 | acylglycerol homeostasis (GO:0055090) | 4.12623714 |
25 | triglyceride homeostasis (GO:0070328) | 4.12623714 |
26 | bile acid biosynthetic process (GO:0006699) | 4.11843649 |
27 | nitrogen cycle metabolic process (GO:0071941) | 4.10471122 |
28 | negative regulation of protein activation cascade (GO:2000258) | 4.07377268 |
29 | protein activation cascade (GO:0072376) | 4.06821205 |
30 | bile acid metabolic process (GO:0008206) | 4.01163058 |
31 | opsonization (GO:0008228) | 4.00848741 |
32 | cellular glucuronidation (GO:0052695) | 3.92383776 |
33 | complement activation (GO:0006956) | 3.90666437 |
34 | drug metabolic process (GO:0017144) | 3.83131479 |
35 | regulation of triglyceride catabolic process (GO:0010896) | 3.82462538 |
36 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.82433601 |
37 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.82433601 |
38 | negative regulation of blood coagulation (GO:0030195) | 3.82057246 |
39 | negative regulation of hemostasis (GO:1900047) | 3.82057246 |
40 | urea cycle (GO:0000050) | 3.80373107 |
41 | phenylpropanoid metabolic process (GO:0009698) | 3.79391660 |
42 | acute-phase response (GO:0006953) | 3.79006637 |
43 | triglyceride catabolic process (GO:0019433) | 3.78713968 |
44 | plasma lipoprotein particle clearance (GO:0034381) | 3.77731833 |
45 | aromatic amino acid family catabolic process (GO:0009074) | 3.77310953 |
46 | neutral lipid catabolic process (GO:0046461) | 3.70569448 |
47 | acylglycerol catabolic process (GO:0046464) | 3.70569448 |
48 | oxidative demethylation (GO:0070989) | 3.69691364 |
49 | complement activation, classical pathway (GO:0006958) | 3.68006683 |
50 | negative regulation of sterol transport (GO:0032372) | 3.65816659 |
51 | negative regulation of cholesterol transport (GO:0032375) | 3.65816659 |
52 | uronic acid metabolic process (GO:0006063) | 3.62287344 |
53 | glucuronate metabolic process (GO:0019585) | 3.62287344 |
54 | daunorubicin metabolic process (GO:0044597) | 3.61895200 |
55 | polyketide metabolic process (GO:0030638) | 3.61895200 |
56 | doxorubicin metabolic process (GO:0044598) | 3.61895200 |
57 | * protein-lipid complex remodeling (GO:0034368) | 3.60018287 |
58 | * macromolecular complex remodeling (GO:0034367) | 3.60018287 |
59 | * plasma lipoprotein particle remodeling (GO:0034369) | 3.60018287 |
60 | positive regulation of blood coagulation (GO:0030194) | 3.58485062 |
61 | positive regulation of hemostasis (GO:1900048) | 3.58485062 |
62 | regulation of lipoprotein metabolic process (GO:0050746) | 3.54819817 |
63 | negative regulation of coagulation (GO:0050819) | 3.51343022 |
64 | serine family amino acid catabolic process (GO:0009071) | 3.50785225 |
65 | negative regulation of wound healing (GO:0061045) | 3.47000361 |
66 | negative regulation of lipase activity (GO:0060192) | 3.44932913 |
67 | negative regulation of complement activation (GO:0045916) | 3.43315223 |
68 | regulation of humoral immune response (GO:0002920) | 3.39873159 |
69 | positive regulation of lipid catabolic process (GO:0050996) | 3.37103460 |
70 | low-density lipoprotein particle clearance (GO:0034383) | 3.36819560 |
71 | cholesterol efflux (GO:0033344) | 3.34935772 |
72 | high-density lipoprotein particle remodeling (GO:0034375) | 3.33397877 |
73 | glucocorticoid biosynthetic process (GO:0006704) | 3.32602448 |
74 | positive regulation of coagulation (GO:0050820) | 3.25861641 |
75 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.20446883 |
76 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.20217341 |
77 | regulation of apoptotic cell clearance (GO:2000425) | 3.19004836 |
78 | amino-acid betaine metabolic process (GO:0006577) | 3.14880429 |
79 | phospholipid efflux (GO:0033700) | 3.08847508 |
80 | bile acid and bile salt transport (GO:0015721) | 3.06292037 |
81 | reverse cholesterol transport (GO:0043691) | 3.05960845 |
82 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.03102737 |
83 | acute inflammatory response (GO:0002526) | 3.02876587 |
84 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.02653450 |
85 | glycine metabolic process (GO:0006544) | 3.01144056 |
86 | intestinal cholesterol absorption (GO:0030299) | 2.99307523 |
87 | regulation of bile acid biosynthetic process (GO:0070857) | 2.99023197 |
88 | response to phenylpropanoid (GO:0080184) | 2.98695802 |
89 | * regulation of cholesterol esterification (GO:0010872) | 2.97917687 |
90 | imidazole-containing compound metabolic process (GO:0052803) | 2.97906064 |
91 | primary alcohol metabolic process (GO:0034308) | 2.95751968 |
92 | positive regulation of wound healing (GO:0090303) | 2.95461510 |
93 | primary alcohol catabolic process (GO:0034310) | 2.94704343 |
94 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.94212175 |
95 | response to mercury ion (GO:0046689) | 2.93799803 |
96 | cytolysis (GO:0019835) | 2.93105417 |
97 | tyrosine metabolic process (GO:0006570) | 2.92198689 |
98 | phospholipid homeostasis (GO:0055091) | 2.89430613 |
99 | glutamate metabolic process (GO:0006536) | 2.84357852 |
100 | regulation of sequestering of triglyceride (GO:0010889) | 2.83225076 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.91159628 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.88679548 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.48359440 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.88976898 |
5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.86136666 |
6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.81491584 |
7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.67334067 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.59739049 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.09964877 |
10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.55242914 |
11 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.15103777 |
12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11300593 |
13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.04811528 |
14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.03385923 |
15 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.01451788 |
16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.78569514 |
17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78016282 |
18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74889879 |
19 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.66404094 |
20 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.58867524 |
21 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54580516 |
22 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.54150027 |
23 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.49989595 |
24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.43190595 |
25 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.43190595 |
26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42747569 |
27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.38597968 |
28 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.37425100 |
29 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.37425100 |
30 | CJUN_26792858_Chip-Seq_BT549_Human | 1.36240063 |
31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30254378 |
32 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.29841177 |
33 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.29841177 |
34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.28884767 |
35 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27805592 |
36 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27353534 |
37 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27089232 |
38 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27030757 |
39 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.25692490 |
40 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.24707128 |
41 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.23518400 |
42 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.22261471 |
43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16974031 |
44 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16409733 |
45 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13209899 |
46 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.12748636 |
47 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11201803 |
48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06887499 |
49 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06516705 |
50 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.06329445 |
51 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06066119 |
52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01823672 |
53 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.01423354 |
54 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.00171827 |
55 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98461034 |
56 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96354387 |
57 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95898952 |
58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95803109 |
59 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93658091 |
60 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92724604 |
61 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.92690971 |
62 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.91817774 |
63 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.90800211 |
64 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.88262366 |
65 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.87390454 |
66 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87262294 |
67 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.87092996 |
68 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.86947401 |
69 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.86254108 |
70 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.85150678 |
71 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.83764058 |
72 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.83380812 |
73 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82691661 |
74 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.82677417 |
75 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.82038926 |
76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81735362 |
77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.80845607 |
78 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80045380 |
79 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76107329 |
80 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.75451770 |
81 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.75001391 |
82 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.74998929 |
83 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.74976538 |
84 | CBP_21632823_ChIP-Seq_H3396_Human | 0.74446036 |
85 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73877678 |
86 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.72014365 |
87 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71815717 |
88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71585123 |
89 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.70757070 |
90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.70545561 |
91 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.69984318 |
92 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.69954638 |
93 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.67110887 |
94 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.65504839 |
95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.65374443 |
96 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.65290456 |
97 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.64961108 |
98 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.64625796 |
99 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.64269380 |
100 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.63847377 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.08887924 |
2 | MP0008438_abnormal_cutaneous_collagen | 4.79391096 |
3 | MP0005365_abnormal_bile_salt | 4.14801459 |
4 | MP0005360_urolithiasis | 3.70877115 |
5 | MP0010368_abnormal_lymphatic_system | 3.59765491 |
6 | MP0005085_abnormal_gallbladder_physiolo | 3.35906865 |
7 | MP0005670_abnormal_white_adipose | 3.27084033 |
8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.07301692 |
9 | MP0002138_abnormal_hepatobiliary_system | 2.86270467 |
10 | MP0010329_abnormal_lipoprotein_level | 2.80951770 |
11 | MP0005503_abnormal_tendon_morphology | 2.62594447 |
12 | MP0003868_abnormal_feces_composition | 2.55864406 |
13 | MP0005275_abnormal_skin_tensile | 2.54960413 |
14 | MP0004272_abnormal_basement_membrane | 2.51716227 |
15 | MP0003252_abnormal_bile_duct | 2.39625057 |
16 | MP0003195_calcinosis | 2.36500364 |
17 | MP0005666_abnormal_adipose_tissue | 2.15112179 |
18 | MP0002971_abnormal_brown_adipose | 2.02984822 |
19 | MP0003705_abnormal_hypodermis_morpholog | 2.01318264 |
20 | MP0001958_emphysema | 1.99328833 |
21 | MP0001661_extended_life_span | 1.97654621 |
22 | MP0004130_abnormal_muscle_cell | 1.91831402 |
23 | MP0005375_adipose_tissue_phenotype | 1.81147199 |
24 | MP0002876_abnormal_thyroid_physiology | 1.81136343 |
25 | MP0003191_abnormal_cellular_cholesterol | 1.71582387 |
26 | MP0000751_myopathy | 1.69354270 |
27 | MP0003279_aneurysm | 1.67478061 |
28 | MP0002118_abnormal_lipid_homeostasis | 1.61081139 |
29 | MP0002108_abnormal_muscle_morphology | 1.59719678 |
30 | MP0001666_abnormal_nutrient_absorption | 1.57613452 |
31 | MP0005332_abnormal_amino_acid | 1.44129968 |
32 | MP0000013_abnormal_adipose_tissue | 1.43894185 |
33 | MP0009840_abnormal_foam_cell | 1.42137694 |
34 | MP0000609_abnormal_liver_physiology | 1.41938409 |
35 | MP0000003_abnormal_adipose_tissue | 1.40382158 |
36 | MP0003950_abnormal_plasma_membrane | 1.34986716 |
37 | MP0001879_abnormal_lymphatic_vessel | 1.34060131 |
38 | MP0009115_abnormal_fat_cell | 1.26842755 |
39 | MP0005595_abnormal_vascular_smooth | 1.26141518 |
40 | MP0005334_abnormal_fat_pad | 1.13557030 |
41 | MP0001542_abnormal_bone_strength | 1.12869661 |
42 | MP0005023_abnormal_wound_healing | 1.11706865 |
43 | MP0005164_abnormal_response_to | 1.11337195 |
44 | MP0006138_congestive_heart_failure | 1.11253049 |
45 | MP0003186_abnormal_redox_activity | 1.09792201 |
46 | MP0003959_abnormal_lean_body | 1.08279504 |
47 | MP0009780_abnormal_chondrocyte_physiolo | 1.07163216 |
48 | MP0002295_abnormal_pulmonary_circulatio | 1.05599445 |
49 | MP0009384_cardiac_valve_regurgitation | 1.04854070 |
50 | MP0009697_abnormal_copulation | 1.01998521 |
51 | MP0004185_abnormal_adipocyte_glucose | 1.00865619 |
52 | MP0000767_abnormal_smooth_muscle | 0.99171686 |
53 | MP0004145_abnormal_muscle_electrophysio | 0.93471486 |
54 | MP0004087_abnormal_muscle_fiber | 0.92467912 |
55 | MP0005535_abnormal_body_temperature | 0.91503804 |
56 | MP0004883_abnormal_blood_vessel | 0.90199530 |
57 | MP0003690_abnormal_glial_cell | 0.89649107 |
58 | MP0000639_abnormal_adrenal_gland | 0.89130194 |
59 | MP0003566_abnormal_cell_adhesion | 0.88878823 |
60 | MP0005379_endocrine/exocrine_gland_phen | 0.87151312 |
61 | MP0000759_abnormal_skeletal_muscle | 0.86454953 |
62 | MP0001915_intracranial_hemorrhage | 0.85788137 |
63 | MP0001764_abnormal_homeostasis | 0.82651831 |
64 | MP0002909_abnormal_adrenal_gland | 0.82493537 |
65 | MP0005319_abnormal_enzyme/_coenzyme | 0.81447566 |
66 | MP0008775_abnormal_heart_ventricle | 0.81051864 |
67 | MP0005620_abnormal_muscle_contractility | 0.79599153 |
68 | MP0005647_abnormal_sex_gland | 0.77600946 |
69 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76976760 |
70 | MP0000249_abnormal_blood_vessel | 0.76777240 |
71 | MP0002128_abnormal_blood_circulation | 0.75903923 |
72 | MP0004019_abnormal_vitamin_homeostasis | 0.75720977 |
73 | MP0002060_abnormal_skin_morphology | 0.75327730 |
74 | MP0002970_abnormal_white_adipose | 0.73087582 |
75 | MP0003011_delayed_dark_adaptation | 0.72728422 |
76 | MP0005448_abnormal_energy_balance | 0.72698747 |
77 | MP0000598_abnormal_liver_morphology | 0.72556960 |
78 | MP0002078_abnormal_glucose_homeostasis | 0.72469948 |
79 | MP0000343_altered_response_to | 0.71458009 |
80 | MP0005508_abnormal_skeleton_morphology | 0.71097262 |
81 | MP0005330_cardiomyopathy | 0.70983943 |
82 | MP0005369_muscle_phenotype | 0.69365960 |
83 | MP0002269_muscular_atrophy | 0.69048523 |
84 | MP0000749_muscle_degeneration | 0.68400493 |
85 | MP0009643_abnormal_urine_homeostasis | 0.68219836 |
86 | MP0001544_abnormal_cardiovascular_syste | 0.67408012 |
87 | MP0005385_cardiovascular_system_phenoty | 0.67408012 |
88 | MP0002896_abnormal_bone_mineralization | 0.67385334 |
89 | MP0005408_hypopigmentation | 0.61531622 |
90 | MP0005376_homeostasis/metabolism_phenot | 0.61058075 |
91 | MP0003941_abnormal_skin_development | 0.60715766 |
92 | MP0004036_abnormal_muscle_relaxation | 0.60491921 |
93 | MP0003091_abnormal_cell_migration | 0.60182926 |
94 | MP0005220_abnormal_exocrine_pancreas | 0.60146947 |
95 | MP0005257_abnormal_intraocular_pressure | 0.59690719 |
96 | MP0004215_abnormal_myocardial_fiber | 0.59507759 |
97 | MP0000230_abnormal_systemic_arterial | 0.58796355 |
98 | MP0005187_abnormal_penis_morphology | 0.57132095 |
99 | MP0002933_joint_inflammation | 0.56562943 |
100 | MP0005623_abnormal_meninges_morphology | 0.54940169 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Complement deficiency (HP:0004431) | 8.36679970 |
2 | Deep venous thrombosis (HP:0002625) | 6.97777399 |
3 | Abnormality of complement system (HP:0005339) | 6.85886524 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.22282963 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 5.75630562 |
6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.70826254 |
7 | Systemic lupus erythematosus (HP:0002725) | 4.97618117 |
8 | Hypobetalipoproteinemia (HP:0003563) | 4.75150669 |
9 | Joint hemorrhage (HP:0005261) | 4.62032528 |
10 | Glomerulonephritis (HP:0000099) | 4.40365413 |
11 | Protrusio acetabuli (HP:0003179) | 4.35791798 |
12 | Premature rupture of membranes (HP:0001788) | 4.15750623 |
13 | Hyperlipoproteinemia (HP:0010980) | 4.07442797 |
14 | Conjugated hyperbilirubinemia (HP:0002908) | 4.02307585 |
15 | Xanthomatosis (HP:0000991) | 3.97084935 |
16 | Mitral stenosis (HP:0001718) | 3.61210583 |
17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.47715593 |
18 | Intrahepatic cholestasis (HP:0001406) | 3.40215261 |
19 | Hypolipoproteinemia (HP:0010981) | 3.32925824 |
20 | Aortic dissection (HP:0002647) | 3.30232500 |
21 | Nephritis (HP:0000123) | 3.19556185 |
22 | Type 1 muscle fiber predominance (HP:0003803) | 3.05609716 |
23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.04883681 |
24 | Spontaneous abortion (HP:0005268) | 2.99462399 |
25 | Abnormality of the intrinsic pathway (HP:0010989) | 2.91669599 |
26 | Aortic aneurysm (HP:0004942) | 2.90235022 |
27 | Cardiovascular calcification (HP:0011915) | 2.85889376 |
28 | Hypoalphalipoproteinemia (HP:0003233) | 2.85464854 |
29 | Vascular tortuosity (HP:0004948) | 2.84014898 |
30 | Round ear (HP:0100830) | 2.82013667 |
31 | Soft skin (HP:0000977) | 2.69769111 |
32 | Hypercholesterolemia (HP:0003124) | 2.67759223 |
33 | Hemorrhage of the eye (HP:0011885) | 2.63039874 |
34 | Rickets (HP:0002748) | 2.62140795 |
35 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.61595739 |
36 | Vascular calcification (HP:0004934) | 2.61402540 |
37 | Abnormal delivery (HP:0001787) | 2.59018176 |
38 | Peritonitis (HP:0002586) | 2.58830939 |
39 | Increased variability in muscle fiber diameter (HP:0003557) | 2.50978693 |
40 | Atrioventricular block (HP:0001678) | 2.46992401 |
41 | Wrist flexion contracture (HP:0001239) | 2.43864114 |
42 | Fat malabsorption (HP:0002630) | 2.43177117 |
43 | Osteomalacia (HP:0002749) | 2.36347076 |
44 | Arterial tortuosity (HP:0005116) | 2.33957158 |
45 | Spinal rigidity (HP:0003306) | 2.31354770 |
46 | Arthropathy (HP:0003040) | 2.30247157 |
47 | Increased connective tissue (HP:0009025) | 2.22783701 |
48 | Skin nodule (HP:0200036) | 2.20490822 |
49 | Vertebral compression fractures (HP:0002953) | 2.20255753 |
50 | Myocardial infarction (HP:0001658) | 2.20125400 |
51 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.19259200 |
52 | Epidermoid cyst (HP:0200040) | 2.17204188 |
53 | Back pain (HP:0003418) | 2.16142800 |
54 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.14579357 |
55 | Mitral valve prolapse (HP:0001634) | 2.13459500 |
56 | Overgrowth (HP:0001548) | 2.06573511 |
57 | Cerebral aneurysm (HP:0004944) | 2.05428497 |
58 | Polycythemia (HP:0001901) | 2.04891863 |
59 | Hypertriglyceridemia (HP:0002155) | 2.04697076 |
60 | Gingival bleeding (HP:0000225) | 2.04366161 |
61 | Neonatal hypoglycemia (HP:0001998) | 2.02851479 |
62 | Blue sclerae (HP:0000592) | 2.00088502 |
63 | Bladder diverticulum (HP:0000015) | 1.98661669 |
64 | Infantile muscular hypotonia (HP:0008947) | 1.97941493 |
65 | Steatorrhea (HP:0002570) | 1.94515903 |
66 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.92884847 |
67 | Fragile skin (HP:0001030) | 1.92508510 |
68 | Hyperphosphaturia (HP:0003109) | 1.91162374 |
69 | Abnormality of the Achilles tendon (HP:0005109) | 1.91105850 |
70 | Dilatation of the ascending aorta (HP:0005111) | 1.89378657 |
71 | Ectopia lentis (HP:0001083) | 1.88785773 |
72 | Oligomenorrhea (HP:0000876) | 1.88242204 |
73 | Wormian bones (HP:0002645) | 1.83760074 |
74 | Ankle contracture (HP:0006466) | 1.83529939 |
75 | Joint stiffness (HP:0001387) | 1.80616557 |
76 | Acanthosis nigricans (HP:0000956) | 1.80547347 |
77 | Broad metatarsal (HP:0001783) | 1.80466373 |
78 | Hypophosphatemic rickets (HP:0004912) | 1.79218393 |
79 | Follicular hyperkeratosis (HP:0007502) | 1.78630057 |
80 | Asymmetric septal hypertrophy (HP:0001670) | 1.77391340 |
81 | Glycosuria (HP:0003076) | 1.76215892 |
82 | Abnormality of urine glucose concentration (HP:0011016) | 1.76215892 |
83 | Biconcave vertebral bodies (HP:0004586) | 1.75405645 |
84 | Aneurysm (HP:0002617) | 1.75014642 |
85 | Atrophic scars (HP:0001075) | 1.72256207 |
86 | Venous insufficiency (HP:0005293) | 1.71288183 |
87 | Abnormal atrioventricular conduction (HP:0005150) | 1.70935613 |
88 | Hyperextensible skin (HP:0000974) | 1.70337879 |
89 | Hyperammonemia (HP:0001987) | 1.69217119 |
90 | Delayed CNS myelination (HP:0002188) | 1.66322157 |
91 | Heart block (HP:0012722) | 1.66282032 |
92 | Thrombophlebitis (HP:0004418) | 1.65966415 |
93 | Menorrhagia (HP:0000132) | 1.65955002 |
94 | Amyloidosis (HP:0011034) | 1.65512321 |
95 | Nemaline bodies (HP:0003798) | 1.65220127 |
96 | Purpura (HP:0000979) | 1.64785902 |
97 | Muscle fiber splitting (HP:0003555) | 1.62551853 |
98 | Venous abnormality (HP:0002624) | 1.62139697 |
99 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.61786827 |
100 | Muscle fiber inclusion bodies (HP:0100299) | 1.60849892 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K6 | 3.98587449 |
2 | PIK3CG | 3.77623051 |
3 | DDR2 | 2.90304487 |
4 | ERN1 | 2.86567235 |
5 | RIPK1 | 2.84488336 |
6 | PDGFRA | 2.83338646 |
7 | MYLK | 2.79933819 |
8 | TRIB3 | 2.61800405 |
9 | TGFBR2 | 2.46145247 |
10 | FGFR4 | 2.25409066 |
11 | TRPM7 | 2.17578572 |
12 | EEF2K | 2.01398233 |
13 | TIE1 | 1.99771537 |
14 | NEK9 | 1.98596264 |
15 | SIK1 | 1.89228837 |
16 | TTN | 1.85593734 |
17 | OBSCN | 1.83013892 |
18 | AKT3 | 1.76899004 |
19 | MAP2K4 | 1.71736495 |
20 | PRKAA2 | 1.61430876 |
21 | MAP2K7 | 1.58381002 |
22 | LATS1 | 1.57843215 |
23 | LATS2 | 1.54471678 |
24 | PIK3CA | 1.45103672 |
25 | MAPKAPK3 | 1.36396480 |
26 | MAP3K4 | 1.34839206 |
27 | ICK | 1.28798517 |
28 | EPHB2 | 1.27884992 |
29 | MOS | 1.20903126 |
30 | EPHA3 | 1.19524858 |
31 | TESK1 | 1.18494490 |
32 | PTK2 | 1.17733683 |
33 | RET | 1.11016790 |
34 | PDGFRB | 1.10323630 |
35 | DAPK2 | 1.08942586 |
36 | MAPK7 | 1.07079833 |
37 | ABL2 | 1.05708039 |
38 | MUSK | 0.97340936 |
39 | PAK2 | 0.96203616 |
40 | CAMKK2 | 0.90363377 |
41 | PRKACG | 0.89456651 |
42 | DAPK3 | 0.89050005 |
43 | MAPK12 | 0.86807775 |
44 | STK16 | 0.85542881 |
45 | PDPK1 | 0.85392324 |
46 | CDC42BPA | 0.83826318 |
47 | FGFR3 | 0.80541908 |
48 | ERBB4 | 0.79262099 |
49 | MAPK11 | 0.75582446 |
50 | MAPK4 | 0.74681910 |
51 | DMPK | 0.74395226 |
52 | MAP3K5 | 0.74339647 |
53 | RPS6KA2 | 0.74165871 |
54 | EPHB1 | 0.73087952 |
55 | PINK1 | 0.70643767 |
56 | MAP3K7 | 0.70096862 |
57 | IRAK3 | 0.69924932 |
58 | TYK2 | 0.69784797 |
59 | NLK | 0.69052268 |
60 | MTOR | 0.67886192 |
61 | CAMK1D | 0.67765338 |
62 | LIMK1 | 0.66755348 |
63 | NTRK1 | 0.66565327 |
64 | PRKG1 | 0.66278304 |
65 | PRKAA1 | 0.66148143 |
66 | MET | 0.65908408 |
67 | CAMK1G | 0.65463465 |
68 | MAP2K1 | 0.64892254 |
69 | GSK3A | 0.59573216 |
70 | STK3 | 0.59489688 |
71 | KIT | 0.58399558 |
72 | JAK1 | 0.56113201 |
73 | MAP3K3 | 0.54106489 |
74 | ILK | 0.53434652 |
75 | PAK3 | 0.53035975 |
76 | CAMK1 | 0.51345423 |
77 | CAMK2D | 0.51315009 |
78 | KSR2 | 0.50371774 |
79 | PKN2 | 0.50161194 |
80 | ROCK1 | 0.47094924 |
81 | PRPF4B | 0.47041041 |
82 | GRK5 | 0.46003419 |
83 | PHKG2 | 0.44495809 |
84 | PHKG1 | 0.44495809 |
85 | PDK1 | 0.43986494 |
86 | MAPKAPK5 | 0.43976434 |
87 | CDK6 | 0.42714372 |
88 | PRKCE | 0.42296271 |
89 | IGF1R | 0.42159446 |
90 | WNK1 | 0.40368116 |
91 | PRKACA | 0.39992191 |
92 | RPS6KA3 | 0.35583955 |
93 | TBK1 | 0.34544752 |
94 | PRKD2 | 0.34113206 |
95 | CAMK2G | 0.33322460 |
96 | PRKD1 | 0.33137075 |
97 | FER | 0.32694580 |
98 | MARK2 | 0.32559239 |
99 | MAP2K3 | 0.32471739 |
100 | NTRK3 | 0.32138248 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.13524829 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.70454182 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.47045233 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.04547157 |
5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.99484340 |
6 | Retinol metabolism_Homo sapiens_hsa00830 | 2.87602116 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.78569636 |
8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.74183789 |
9 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.73613576 |
10 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.47164184 |
11 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.45340338 |
12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41441174 |
13 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.39876687 |
14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.38486443 |
15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31474484 |
16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.21005420 |
17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.11624601 |
18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.10410520 |
19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.06040913 |
20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78557096 |
21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.71999877 |
22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.66597657 |
23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.65333766 |
24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.60736555 |
25 | Bile secretion_Homo sapiens_hsa04976 | 1.59917302 |
26 | Prion diseases_Homo sapiens_hsa05020 | 1.56228995 |
27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.51570307 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.42249599 |
29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.29600243 |
30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.24187628 |
31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.18993682 |
32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.14995227 |
33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.14323514 |
34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.12900686 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12207299 |
36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.10134001 |
37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.06442540 |
38 | Peroxisome_Homo sapiens_hsa04146 | 1.05784104 |
39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.05714426 |
40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99927059 |
41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99428786 |
42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97763760 |
43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93561552 |
44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93110957 |
45 | ABC transporters_Homo sapiens_hsa02010 | 0.88915622 |
46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87301305 |
47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84491655 |
48 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.83258281 |
49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82612445 |
50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77914987 |
51 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76685910 |
52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73576231 |
53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71717108 |
54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71021350 |
55 | Insulin resistance_Homo sapiens_hsa04931 | 0.70385378 |
56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67348977 |
57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67119324 |
58 | Pertussis_Homo sapiens_hsa05133 | 0.63260514 |
59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60515150 |
60 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59499171 |
61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55684552 |
62 | Lysine degradation_Homo sapiens_hsa00310 | 0.54583241 |
63 | Amoebiasis_Homo sapiens_hsa05146 | 0.51335731 |
64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46260993 |
65 | Focal adhesion_Homo sapiens_hsa04510 | 0.44758081 |
66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43060008 |
67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40084253 |
68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38448840 |
69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37932462 |
70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37560779 |
71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.35524914 |
72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.34629438 |
73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33716415 |
74 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32908436 |
75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.29354502 |
76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27784893 |
77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27393713 |
78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.24775867 |
79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24136851 |
80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23841553 |
81 | Malaria_Homo sapiens_hsa05144 | 0.18288446 |
82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.17137446 |
83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.16590664 |
84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.16521402 |
85 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.16232986 |
86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15427057 |
87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.14831611 |
88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.14178693 |
89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.13741445 |
90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.13535590 |
91 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.12626804 |
92 | Mineral absorption_Homo sapiens_hsa04978 | 0.11418856 |
93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.10421255 |
94 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.05884084 |
95 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.04705784 |
96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.04299037 |
97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.03870757 |
98 | * Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02891687 |
99 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.02885226 |
100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.01643763 |